Literature DB >> 8551047

Detection of intracellular HIV-1 Rev protein by flow cytometry.

R J Rigg1, J S Dando, S Escaich, I Plavec, E Böhnlein.   

Abstract

The Rev trans-activator protein plays a pivotal role in human immunodeficiency virus type 1 (HIV-1) replication by allowing expression of the viral structural proteins. We have developed a protocol to quantitatively assay intracellular steady state levels of Rev Ag (Rev wild type and RevM10 proteins) by flow cytometry. Three fixation and permeabilization techniques were compared. These protocols varied in the magnitude of the signal which could be detected, and in the ability to distinguish between Rev Ag positive and negative populations. This technology is applicable to a variety transduced or transfected cell types (species, lineage), and for cell lines and primary cells acutely infected with HIV-1. The assay is therefore a valuable tool both to analyze Rev protein expression levels in HIV-infected cells and to optimize delivery of the dominant-negative RevM10 gene for clinical gene therapy applications. In addition, a second, independent intracellular protein (HIV-Tat) has been detected using the same approach.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551047     DOI: 10.1016/0022-1759(95)00237-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms.

Authors:  G Kovalev; K Duus; L Wang; R Lee; M Bonyhadi; D Ho; J M McCune; H Kaneshima; L Su
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

2.  Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.

Authors:  U Junker; S Escaich; I Plavec; J Baker; F McPhee; J R Rose; C S Craik; E Böhnlein
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.

Authors:  M L Bonyhadi; K Moss; A Voytovich; J Auten; C Kalfoglou; I Plavec; S Forestell; L Su; E Böhnlein; H Kaneshima
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.

Authors:  G Veres; U Junker; J Baker; C Barske; C Kalfoglou; H Ilves; S Escaich; H Kaneshima; E Böhnlein
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes.

Authors:  G Veres; S Escaich; J Baker; C Barske; C Kalfoglou; H Ilves; H Kaneshima; E Böhnlein
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.

Authors:  Sekar Natesampillai; Zilin Nie; Nathan W Cummins; Dirk Jochmans; Gary D Bren; Jonathan B Angel; Andrew D Badley
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

7.  Synthesis of fluorescence labelled aptamers for use as low-cost reagents in HIV/AIDS research and diagnostics.

Authors:  Kanyane Malatji; Pascaline N Fru; Hazel Mufhandu; Kabamba Alexandre
Journal:  Biomed Rep       Date:  2021-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.